Biggest News Aggregation in the World
📰 Hookipa Pharma News

Page 2 - Hookipa Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Hookipa Pharma. Real-time updates on events, politics, business and more.

Off the Hookipa: Roche terminates $1B deal

Hookipa Pharma Inc.’s nearly $1 billion collaboration with Roche Holding AG dissolved along with 30% of the company’s staff. The New York-based company said Roche ended the October 2022 deal involving the HB-700 program in treating KRAS mutated cancers but did not say why the agreement fell apart.
Andrew Berens Roche Holding Hookipa Pharma Inc Hookipa Pharma New York Based Gilead Sciences Inc

Hookipa Pharma (NASDAQ:HOOK) Trading Down 16.5%

Shares of Hookipa Pharma Inc (NASDAQ:HOOK – Get Free Report) were down 16.5% during mid-day trading on Monday . The stock traded as low as $0.71 and last traded at $0.72. Approximately 9,262,100 shares were traded during trading, an increase of 749% from the average daily volume of 1,090,797 shares. The stock had previously closed […]
Hookipa Pharma Vanguard Group Inc Walleye Capital Royal Bank Pharma Inc Jefferies Financial Group Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Reported positive preliminary Phase 2 data on additional patients for HB-200 in combination with pembrolizumab in the 1st-line setting for advanced HPV16+ head and neck cancer; data reinforce strong objective response rate and disease control rate reported in Q2 2023; randomized trial expected to start in 2024 Published peer-reviewed preclinical data, in collaboration with Gilead Sciences, for HB-400 program in The Journal of Infectious Disease Recruitment ongoing for two Phase 1 clinical trials
Michael Kaiser Joern Aldag Pharma Inc Gilead Sciences Inc Gilead Sciences Development Expenses
Source: yahoo.com

Hookipa Pharma's (HOOK) Outperform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reiterated their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a research report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has a $7.00 target price on the stock. Several other equities research analysts have also issued reports on HOOK. HC Wainwright lowered their […]
Hookipa Pharma Mirabella Financial Services Virtu Financial Royal Bank Vontobel Holding Ltd Pharma Inc
Source: wkrb13.com

Hookipa Pharma (NASDAQ:HOOK) Earns "Buy" Rating from Truist Financial

Truist Financial restated their buy rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a research note published on Wednesday, Benzinga reports. They currently have a $4.00 price target on the stock. Several other brokerages have also issued reports on HOOK. Royal Bank of Canada reissued an outperform rating and issued a $7.00 […]
Hudson Bay Hookipa Pharma Pharma Inc Knoll Capital Management Royal Bank Walleye Capital

Hookipa Pharma (NASDAQ:HOOK) Announces Earnings Results

Hookipa Pharma (NASDAQ:HOOK – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.01), reports. The company had revenue of $2.68 million during the quarter, compared to the consensus estimate of $3.54 million. Hookipa Pharma had a […]
Hookipa Pharma Royal Bank Pharma Inc Artal Group Alyeska Investment Group Jefferies Financial Group Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science